Literature DB >> 32076988

Federal Barriers to Addressing the Opioid Epidemic.

Robert A Kleinman1, Nathaniel P Morris2.   

Abstract

Mesh：

Substances：

Year:  2020        PMID： 32076988      PMCID： PMC7174483          DOI： 10.1007/s11606-020-05721-5

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  6 in total

Review 1.  Supervised injection services: what has been demonstrated? A systematic literature review.

Authors:  Chloé Potier; Vincent Laprévote; Françoise Dubois-Arber; Olivier Cottencin; Benjamin Rolland
Journal:  Drug Alcohol Depend       Date:  2014-10-23       Impact factor: 4.492

2.  Buprenorphine Deregulation and Mainstreaming Treatment for Opioid Use Disorder: X the X Waiver.

Authors:  Kevin Fiscella; Sarah E Wakeman; Leo Beletsky
Journal:  JAMA Psychiatry       Date:  2019-03-01       Impact factor: 21.596

3.  Geographic Distribution of Providers With a DEA Waiver to Prescribe Buprenorphine for the Treatment of Opioid Use Disorder: A 5-Year Update.

Authors:  C Holly A Andrilla; Tessa E Moore; Davis G Patterson; Eric H Larson
Journal:  J Rural Health       Date:  2018-06-20       Impact factor: 4.333

Review 4.  Heroin on trial: systematic review and meta-analysis of randomised trials of diamorphine-prescribing as treatment for refractory heroin addiction†.

Authors:  John Strang; Teodora Groshkova; Ambros Uchtenhagen; Wim van den Brink; Christian Haasen; Martin T Schechter; Nick Lintzeris; James Bell; Alessandro Pirona; Eugenia Oviedo-Joekes; Roland Simon; Nicola Metrebian
Journal:  Br J Psychiatry       Date:  2015-07       Impact factor: 9.319

5.  Growth In Buprenorphine Waivers For Physicians Increased Potential Access To Opioid Agonist Treatment, 2002-11.

Authors:  Andrew W Dick; Rosalie L Pacula; Adam J Gordon; Mark Sorbero; Rachel M Burns; Douglas Leslie; Bradley D Stein
Journal:  Health Aff (Millwood)       Date:  2015-06       Impact factor: 6.301

Review 6.  Methadone Matters: What the United States Can Learn from the Global Effort to Treat Opioid Addiction.

Authors:  S L Calcaterra; P Bach; A Chadi; N Chadi; S D Kimmel; K L Morford; P Roy; J H Samet
Journal:  J Gen Intern Med       Date:  2019-02-06       Impact factor: 5.128
  6 in total
  2 in total

1.  COVID-19-related policy changes for methadone take-home dosing: A multistate survey of opioid treatment program leadership.

Authors:  Ximena A Levander; Jarratt D Pytell; Kenneth B Stoller; P Todd Korthuis; Geetanjali Chander
Journal:  Subst Abus       Date:  2021-10-19       Impact factor: 3.716

Review 2.  Opioid Use Disorder: Treatments and Barriers.

Authors:  Karan Patel; Sean Bunachita; Ank A Agarwal; Aaron Lyon; Urvish K Patel
Journal:  Cureus       Date:  2021-02-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.